1
|
Recht MP, Donoso-Bach L, Brkljačić B, Chandarana H, Jankharia B, Mahoney MC. Patient-centered radiology: a roadmap for outpatient imaging. Eur Radiol 2024; 34:4331-4340. [PMID: 38047974 DOI: 10.1007/s00330-023-10370-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2023] [Revised: 08/16/2023] [Accepted: 08/31/2023] [Indexed: 12/05/2023]
Abstract
Creating a patient-centered experience is becoming increasingly important for radiology departments around the world. The goal of patient-centered radiology is to ensure that radiology services are sensitive to patients' needs and desires. This article provides a framework for addressing the patient's experience by dividing their imaging journey into three distinct time periods: pre-exam, day of exam, and post-exam. Each time period has aspects that can contribute to patient anxiety. Although there are components of the patient journey that are common in all regions of the world, there are also unique features that vary by location. This paper highlights innovative solutions from different parts of the world that have been introduced in each of these time periods to create a more patient-centered experience. CLINICAL RELEVANCE STATEMENT: Adopting innovative solutions that help patients understand their imaging journey and decrease their anxiety about undergoing an imaging examination are important steps in creating a patient centered imaging experience. KEY POINTS: • Patients often experience anxiety during their imaging journey and decreasing this anxiety is an important component of patient centered imaging. • The patient imaging journey can be divided into three distinct time periods: pre-exam, day of exam, and post-exam. • Although components of the imaging journey are common, there are local differences in different regions of the world that need to be considered when constructing a patient centered experience.
Collapse
Affiliation(s)
- Michael P Recht
- Department of Radiology, NYU Langone Health, New York, NY, USA.
| | - Lluís Donoso-Bach
- Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain
| | - Boris Brkljačić
- Department of Radiology, University Hospital Dubrava Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia
| | | | | | - Mary C Mahoney
- Department of Radiology, University of Cincinnati Medical Center, Cincinnati, USA
| |
Collapse
|
2
|
Hawks C, Viswambaram P, Cloney C, Botha E, Brown M, Chambers S, Paterson C, Hayne D. Nurse-led telephone notification of a prostate cancer diagnosis: Prospective analysis of men's preferences for and experiences of a same-day assessment and diagnostic clinic. Eur J Cancer Care (Engl) 2021; 30:e13493. [PMID: 34309943 DOI: 10.1111/ecc.13493] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2021] [Revised: 05/22/2021] [Accepted: 07/08/2021] [Indexed: 11/28/2022]
Abstract
OBJECTIVE The 'One Stop Prostate Clinic' (OSPC) was a same-day prostate cancer assessment and/or diagnostic clinic. Preferences and experiences of men who received initial telephone notification of their prostate biopsy results (cancer or benign) by the OSPC Clinical Nurse (CN) are reported. METHODS Prospective mixed methods study using survey instrument and thematic analysis of OSPC preferences and experiences. RESULTS One thousand men attended the OSPC between August 2011 and November 2017, 876 underwent prostate biopsies; 790/876 (90%) men consented to telephone notification of biopsy results, 5/876 (1%) declined and 79/876 (9%) were ineligible/not contacted. 220/403 men (55%) returned the OSPC questionnaire; 135/220 (61%) men received a cancer diagnosis, 119/132 (90%) would choose this method again and 7/132 (5.5%) would not and 6/132 (4.5%) were unsure; 94/135 (70%) reported no disadvantages with this notification method. Overall satisfaction rate with the OSPC was 96% (209/218) men. CONCLUSION Initial telephone notification of prostate biopsy results by the OSPC CN was preferred by the vast majority of eligible men. Many men with a cancer diagnosis did not experience any disadvantages. This method of results delivery can be incorporated by other tumour groups.
Collapse
Affiliation(s)
- Cynthia Hawks
- Medical School, Surgery, University of Western Australia, Perth, Western Australia, Australia.,Urology Department, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.,Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Camperdown, New South Wales, Australia
| | - Pravin Viswambaram
- Medical School, Surgery, University of Western Australia, Perth, Western Australia, Australia.,Urology Department, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.,Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Camperdown, New South Wales, Australia
| | - Claire Cloney
- Urology Department, Fiona Stanley Hospital, Murdoch, Western Australia, Australia
| | - Erica Botha
- Urology Department, Fiona Stanley Hospital, Murdoch, Western Australia, Australia
| | - Matthew Brown
- Urology Department, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.,Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Camperdown, New South Wales, Australia
| | - Suzanne Chambers
- Faculty of Health, University of Technology, Sydney, New South Wales, Australia.,Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Camperdown, New South Wales, Australia
| | - Catherine Paterson
- Faculty of Health, Canberra University, Canberra, Australian Capital Territory, Australia.,Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Camperdown, New South Wales, Australia
| | - Dickon Hayne
- Medical School, Surgery, University of Western Australia, Perth, Western Australia, Australia.,Urology Department, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.,Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Camperdown, New South Wales, Australia
| |
Collapse
|